问卷调查的临床试验
总计415376个结果
-
Merck Sharp & Dohme LLC完全的
-
Beijing 302 Hospital未知
-
National Cancer Institute (NCI)撤销慢性淋巴细胞白血病 | III期慢性淋巴细胞白血病 | IV 期慢性淋巴细胞白血病美国
-
Medical University of South CarolinaColumbia University; Mclean Hospital完全的
-
Haukeland University HospitalHoffmann-La Roche; Bergen Prison, Norwegian Correctional Service终止
-
Beijing Kawin Technology Share-Holding Co., Ltd.完全的
-
CureTech LtdTeva Branded Pharmaceutical Products R&D, Inc.终止
-
Chengdu Kanghong Biotech Co., Ltd.未知
-
Tibotec BVBA完全的慢性丙型肝炎法国, 西班牙, 比利时, 德国, 奥地利, 荷兰
-
King Fahad Medical CityKing AbdulAziz City for Science and Technology完全的
-
Gilead Sciences终止丙肝病毒感染美国, 英国, 德国, 加拿大, 波多黎各, 波兰
-
National Institute of Cancerología未知
-
China Medical University Hospital完全的
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.完全的
-
Gustave Roussy, Cancer Campus, Grand Paris终止STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER法国
-
University Hospital, GhentNationaal Kankerplan终止
-
Xiamen Amoytop Biotech Co., Ltd.Peking University People's Hospital完全的
-
Hospital Universitario Ramon y Cajal终止
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical Trials完全的
-
Samsung Medical Center完全的
-
Göteborg UniversityHoffmann-La Roche终止
-
Pusan National University Yangsan HospitalPusan National University Hospital; Inje University; Severance Hospital; Soon Chun Hyang University 和其他合作者未知
-
Gustave Roussy, Cancer Campus, Grand ParisNovartis未知
-
Astellas Pharma IncAstellas Pharma US, Inc.完全的
-
Amgen Research (Munich) GmbH完全的
-
Govind Ballabh Pant HospitalIndian Council of Medical Research; Lady Hardinge Medical College完全的
-
Rigshospitalet, DenmarkDanish Research Centre for Magnetic Resonance未知
-
BioGeneric PharmaXiamen Amoytop Biotech Co., Ltd.未知
-
University of Sao Paulo未知